BioProtocol (BIO) fluctuates 42.5% in 24 hours: EliLilly acquisition news and whale purchases drive rebound
Bitget Pulse2026/04/30 07:46Volatility Overview
In the past 24 hours, the price of BIO rebounded from a low of $0.03204 to a high of $0.04565, with the current quote at $0.0455, marking an overall amplitude of 42.5%. The 24-hour trading volume surged significantly to approximately $179 million, a sharp increase from usual levels, indicating heightened capital activity.
Brief Analysis of Market Movements
- Eli Lilly's acquisition of Crossbridge Bio (a VitaDAO derivative project) triggered BIO to become one of the day's hot coins, driving a price rebound and pushing it to the top of the trending list.
- A whale opened a $602k long position on Hyperliquid, combined with the upcoming Peptide TGE (Token Generation Event) and a staking priority mechanism, stimulating short-term buying interest.
- Technically, the price broke above the 8-hour descending wedge upper boundary, accompanied by increased trading volume, forming a series of higher highs.
Market Views and Outlook
The mainstream sentiment within the community is bullish, with several traders considering it “this week’s free long opportunity,” predicting further movement toward $0.0435-$0.056, but emphasize not to chase highs and to wait for pullbacks to enter, while warning against potential FOMO traps in the evening. Analysts point out the rebound potential at $0.045, but note that attention should be paid to the sustainability of the DeSci sector's valuation.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
VeChain Slides 8.3%: Is This a Healthy Correction or a Bigger Warning Sign?
Stablecoin supply has stalled in 2026, but payments rose by 45% to $480B: Report
The most dangerous divergence in U.S. stocks: ordinary stocks have already plummeted, how much longer can AI giants hold on?
Significantly tightened financial conditions are heavily impacting ordinary stocks in the US stock market, with the median S&P 500 constituent falling 15% from its peak and the equity risk premium dropping below zero. Rising US Treasury yields and oil prices have pushed the financial conditions index sharply higher, resulting in a severe deterioration in breadth beneath the apparent calm of the index. Market divergence is intensifying, raising the core uncertainty of whether ordinary stocks will catch up or the index will converge downward.
Will APT’s price clear $0.87 after Aptos’s launch of Block-STM v2 upgrade?
